Literature DB >> 24768679

When should the β-blocker window in cirrhosis close?

Phillip S Ge1, Bruce A Runyon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24768679     DOI： 10.1053/j.gastro.2014.04.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

Review 1.  Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.

Authors:  Antonio Facciorusso; Sunil Roy; Sarantis Livadas; Adwalia Fevrier-Paul; Clara Wekesa; Ismail Dogu Kilic; Amit Kumar Chaurasia; Mina Sadeq; Nicola Muscatiello
Journal:  Dig Dis Sci       Date:  2018-05-03       Impact factor: 3.199

Review 2.  Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.

Authors:  Tong Li; Wenbo Ke; Ping Sun; Xiang Chen; Ajay Belgaumkar; Yuanjian Huang; Wenjing Xian; Jinjin Li; Qichang Zheng
Journal:  BMJ Open       Date:  2016-05-04       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.